Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2004
07/15/2004US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries
07/15/2004US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics
07/15/2004US20040138211 Antidiabetic agents; hypotensive agents; insulin resistance; antilipemic agents; cardiovascular disorders ; anticholesterol agents
07/15/2004US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same
07/15/2004US20040138172 Drug product for intestinal disease
07/15/2004US20040138150 Motilide compounds
07/15/2004US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction
07/15/2004US20040137570 Immunoglobulin 2
07/15/2004US20040137568 for treatment of infection by injection of dose between 1x103 and 1x107 bacteria per kg
07/15/2004US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis
07/15/2004US20040137557 Remodeling and glycoconjugation of peptides
07/15/2004US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs
07/15/2004US20040137074 Osteoprotegerin in milk
07/15/2004US20040137053 Method for making water soluble a poorly water soluble antiseptic
07/15/2004US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells
07/15/2004US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma
07/15/2004US20040136978 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice
07/15/2004US20040136922 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants
07/15/2004US20040136914 Buccal, polar and non-polar spray containing ondansetron
07/15/2004DE10147991B4 Verfahren zur Diagnose von chronisch entzündlichen Darmerkrankungen A method of diagnosing inflammatory bowel disease
07/14/2004EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
07/14/2004EP1437365A1 Use of cardiotrophin in hepatic diseases
07/14/2004EP1437352A1 Benzimidazole compound, process for producing the same, and use thereof
07/14/2004EP1437344A1 Benzene derivatives,process for preparing the same and use thereof
07/14/2004EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity
07/14/2004EP1437136A1 Compositions comprising cannabinoids
07/14/2004EP1437126A1 Compositions used to alleviate xerostomia and to treat disorders associated with same
07/14/2004EP1436624A1 A method of diagnosis and treatment and agents useful for same
07/14/2004EP1436422A2 Method of determining susceptibility to inflammatory bowel disease
07/14/2004EP1436383A2 Secreted proteins
07/14/2004EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
07/14/2004EP1436380A2 Composition comprising a lactobacillus pentosus strain and uses thereof
07/14/2004EP1436327A1 Ee3-protein family and corresponding dna sequences
07/14/2004EP1436323A1 Crystal structure of baff, and use thereof in drug design
07/14/2004EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents
07/14/2004EP1436318A2 Ncam binding compounds
07/14/2004EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor
07/14/2004EP1436287A2 Small organic molecule regulators of cell proliferation
07/14/2004EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
07/14/2004EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
07/14/2004EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
07/14/2004EP1436264A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
07/14/2004EP1436255A1 Novel compounds and compositions as cathepsin inhibitors
07/14/2004EP1436252A1 Hydroxyfattysulfonic acid analogs
07/14/2004EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
07/14/2004EP1436012A2 Polymer conjugates of opioid antagonists
07/14/2004EP1436011A2 Dendrimers for use in targeted delivery
07/14/2004EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
07/14/2004EP1436005A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants
07/14/2004EP1435998A1 Method for treating hepatitis c virus infection in treatment failure patients
07/14/2004EP1435997A1 Method for treating hepatitis c virus infection in treatment failure patients
07/14/2004EP1435987A1 Method and composition for treating immune complex associated disorders
07/14/2004EP1435984A1 Use of histamine to treat liver disease
07/14/2004EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
07/14/2004EP1435966A2 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags)
07/14/2004EP1435958A1 Use of phosphorodiesterase iv inhibitors
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
07/14/2004EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
07/14/2004EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435946A2 Linked biaryl compounds
07/14/2004EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435925A2 Gap junctions and edhf
07/14/2004EP1435918A1 Highly compressible ethylcellulose for tableting
07/14/2004EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
07/14/2004EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
07/14/2004EP1313440A4 Dental products comprising bone growth enhancing peptide
07/14/2004EP1282391B1 High cleaning dentifrice
07/14/2004EP1235803B1 Urea compounds having muscarinic receptor antagonist activity
07/14/2004EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004EP1210350B1 Water soluble sdz-rad esters
07/14/2004EP1202996B9 Titanium derived compounds, preparation and use thereof
07/14/2004EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/14/2004EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
07/14/2004EP0984774B1 Gastroretentive controlled release microspheres for improved drug delivery
07/14/2004EP0961775B1 Purine l-nucleosides, analogs and uses thereof
07/14/2004EP0825868B1 Prevention or treatment of alimentary tract damage due to chemotherapy or radiation
07/14/2004EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES
07/14/2004EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
07/14/2004CN1512995A Novel ligand for nicotinic acety/choline receptors useful in therapy
07/14/2004CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors
07/14/2004CN1512983A Compounds and compositions as cathepsins inhibitors
07/14/2004CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents
07/14/2004CN1512888A Modified proteins, designer toxins and methosd of making thereof
07/14/2004CN1512883A Crf受体拮抗剂 Crf receptor antagonist
07/14/2004CN1512878A Lipolysis accelerator, cosmetic skin preparation and food or beverage composition each containing the same, and method for reducing body weight and use
07/14/2004CN1511848A Branched chain polyethylene glycol-integrated int3erferon composition and preparation
07/14/2004CN1511830A Compound used as antiphlogistic
07/14/2004CN1511586A Oral digestible film and its preparing process and use
07/14/2004CN1511584A Insect-ant capsule
07/14/2004CN1511574A Medicinal composition for preventing and curing liver fibrosis and its preparing method
07/14/2004CN1511569A Method for producing stomach energy regulating medicine
07/14/2004CN1511567A Method for producing kuijie powder for ulcerative colitis
07/14/2004CN1511563A Method for producing chromatic diarrhea stopping capsule
07/14/2004CN1511562A Slow diarrhea stopping capsule
07/14/2004CN1511552A Medicine for treating gastritis and peptic ulcer
07/14/2004CN1511547A Chinese medicine for reinforcing kidney and supporting yang